Oncternal Therapeutics Investors

Oncternal Therapeutics is an innovative biotechnology company located in Encinitas, California, founded in 2013 The company specializes in the development of novel therapeutics for various cancers, leveraging cutting-edge research and technology Oncternal Therapeutics has attracted significant investment, enabling it to advance its clinical programs and expand its pipeline of potential treatments The firm is recognized for its commitment to improving patient outcomes through targeted therapies and strategic partnerships in the healthcare sector

Employee Number: 11-50
Headquarters: USA
Technology: Others
Estimated Revenue: $1M to $10M
Founded Date: 2013
Investor Type: Accelerators and Incubators
Industry: FemTech